Skip to content
Politically.com Search all
Menu

2026 · 1st Quarter (Jan 1 - Mar 31)

ELEKTA, INC.

Filed by ELEKTA, INC..

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
1st Quarter - Report
Posted
Jun 29, 2026
Income
Not reported
Expenses
$70,000.00
Registrant
ELEKTA, INC.
Filing UUID
217e25b5-fb9d-4f14-ac86-9ddda863630c
Termination date
Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

BUD · Budget/Appropriations

CY2027 Appropriations

ENG · Energy/Nuclear

Gamma Knife/Cobalt-60

HCR · Health Issues

Radiation Oncology, Oncology, other Cancer Care related issues

MED · Medical/Disease Research/Clinical Labs

Medical Device, Clinical trials

ACC · Accounting

N/A

MMM · Medicare/Medicaid

ROCR, HR1031 and S.2120

Literal federal measure citations: HR1031, S.2120

TAR · Tariff (miscellaneous tariff bills)

General Tariff issues USMCA US-EU trade agreement US-UK trade agreement

TRD · Trade (domestic/foreign)

General Medical Device Trade issues

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.